European Programs
The European Programs constitute the key funding instrument of the European Union for research and innovation. Their aim is the generation of science and technology at a global level that will boost economic growth.
National Programs
The PA (Partnership Agreement for the Development Framework) 2014-2020 is the key strategic plan for growth in Greece with the contribution of significant resources from the European Structural and Investment Funds (ESIFs) of the European Union.
Disclosure Guidelines
The Disclosure Guidelines for the programs of various Funding Bodies are listed on this page.
Technology Transfer Guide - Description
The Technology Transfer Guide is part of the Special Account Funding and Management Guide, hereinafter SARF, for the utilization of funds for scientific research, education, training, technological development and provision of relevant services, set up by virtue of Joint Ministerial Decision, No. 679/22.08.1996 on the “Amendment and replacement of decision No.
Quality Management System (ISO 9001:2015)
Objective:
Quality Policy
Our VISION is the Special Account for Research Funds (SARF) to operate based on the best possible satisfaction of the serviced parties, to play a decisive role in the sector of claiming, administering and implementing European and National co-funded Programs and to constitute a di
The concept of invention (briefly)
An invention is a technical fabrication, which means a product, a method or a new use of an already known product that is:
Confidentiality and secrecy
The disclosure of an invention suspends the right to submit a Patent award application. Whatever the researchers’ decision about submittin
Prsentation of Research Program: Development and study of innovative endovascular balloon system for the local administration of innovative drug (ClEver Balloon).
The project ClEver BALLOON aims at the development of a new medical device for the treatment of arterial disease, an endovascular drug coated balloon catheter (DCB). The product is expected to achieve effective local administration of everolimus, a known but innovative for this specific application drug, with the use of an innovative “ClEver” drug release system that has been patented by the project partners with two international patents. The project includes development of prototypes, in vivo, in vitro and in silico studies.